Tech Company Financing Transactions
Nuron Biotech Funding Round
Private investors participated in a $22.7 million funding round for Nuron Biotech. The round closed on 3/10/2014.
Transaction Overview
Company Name
Announced On
3/10/2014
Transaction Type
Online Capital
Online Capital
Online Capital
Amount
$22,700,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. Not an offer or solicitation for sale of securities. Please contact technology company for solicitation details.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
1 East Uwchlan Ave. 302
Exton, PA 19341
USA
Exton, PA 19341
USA
Phone
Website
Email Address
Overview
Nuron Biotech is developing novel biologics and vaccines for the prevention and treatment of neurodegenerative and infectious diseases. Our team of industry veterans is advancing products to meet unmet medical needs in the areas of multiple sclerosis, Alzheimer's, Hepatitis B and Hepatitis C for patients across the globe.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Warren Cooper
Chief Financial Officer
Wendy DiCicco
Chief Medical Officer
Robert Walker
VP - General Counsel
Andrew Romberger
VP - Manufacturing
Tharuvai Ramesh
VP - R & D
Daniel Cushing
Browse more venture capital transactions:
Prev: 3/10/2014: Mageca venture capital transaction
Next: 3/10/2014: Secret venture capital transaction
Share this article
News on VC Transactions
Our team works diligently to report on every notable VC transaction. VC investment data records on this site are sourced from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs